Canada Stomach Cancer Treatment Market Size & Outlook
Related Markets
Canada stomach cancer treatment market highlights
- The Canada stomach cancer treatment market generated a revenue of USD 96.8 million in 2024 and is expected to reach USD 239.3 million by 2030.
- The Canada market is expected to grow at a CAGR of 15.6% from 2025 to 2030.
- In terms of segment, targeted therapy was the largest revenue generating treatment type in 2024.
- Immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
Stomach cancer treatment market data book summary
| Market revenue in 2024 | USD 96.8 million |
| Market revenue in 2030 | USD 239.3 million |
| Growth rate | 15.6% (CAGR from 2025 to 2030) |
| Largest segment | Targeted therapy |
| Fastest growing segment | Immunotherapy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standard Chemotherapy, Targeted Therapy, Immunotherapy |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis |
Other key industry trends
- In terms of revenue, Canada accounted for 1.8% of the global stomach cancer treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. stomach cancer treatment market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 23.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stomach Cancer Treatment Market Scope
Stomach Cancer Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Samsung Bioepis | View profile | 501-1000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbioepis.com |
| Celltrion Healthcare | View profile | 51-100 | Incheon, Inch'on-jikhalsi, South Korea, Asia | http://www.celltrionhealthcare.com/ |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Canada stomach cancer treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.
Targeted therapy was the largest segment with a revenue share of 49.07% in 2024. Horizon Databook has segmented the Canada stomach cancer treatment market based on standard chemotherapy, targeted therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada stomach cancer treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada stomach cancer treatment market databook
-
Our clientele includes a mix of stomach cancer treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada stomach cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Canada stomach cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada stomach cancer treatment market size, by treatment type, 2018-2030 (US$M)
Canada Stomach Cancer Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
